In July 2024, Checkpoint announced that the FDA accepted for review the resubmission of its BLA for cosibelimab as a complete response to the complete response letter (“CRL”) issued in December 2023 ...

The independent broker-dealer's latest partner firm, formerly with Cadaret Grant and its acquirer LPL, expects substantial benefits as it streamlines its operations.

A lottery player won $50,000 playing Powerball in Massachusetts on Monday. The winning numbers for the Powerball drawing on ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

Third quarter reported revenue of $155 million, an increase of 10% year-over-yearCDMO revenue and orders both up ~20% year-over-yearOverall order ...

Repligen Corporation, established in 1981 and headquartered in Waltham, Massachusetts, is a global life sciences company ...

Initiated the Phase 2 MoonStone trial, a Phase 2, multicenter, randomized, double-blind, placebo-controlled trial, to evaluate the efficacy and safety of obexelimab in patients with Relapsing Multiple ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported a loss of $653,000 in its third quarter. On a per-share basis, the Waltham, Massachusetts-based company said it ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

On Friday, Nov. 8 the Brandeis Swim and Dive team took on the Bentley University Falcons. Taking place at Bentley University to continue the war of Waltham, Brandeis swam away with losses on both the ...